Diferencia entre revisiones de «Tamsulosin»
(Text replacement - "-->" to "→") |
|||
| Línea 40: | Línea 40: | ||
==See Also== | ==See Also== | ||
*[[EBQ:Alpha-blockers for ureteral stone expulsion]] | *[[EBQ:Alpha-blockers for ureteral stone expulsion]] | ||
*[[Urolithiasis]] | |||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Revisión del 00:31 18 abr 2017
Administration
- Type: Alpha blocker
- Dosage Forms:
- Routes of Administration: oral
- Common Trade Names: Flomax
Adult Dosing
- 0.4mg PO once daily
Pediatric Dosing
Safety/efficacy not established
Special Populations
- Pregnancy Rating: B
- Lactation risk: Infant risk cannot be ruled out
Renal Dosing
- Adult: No adjustment for CrCl >10
Hepatic Dosing
- Adult: No adjustment
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Retinal detachment
- Priapism
Common
- Headache, dizziness, insomnia, somnolence
- Abnormal ejaculation
- Rhinitis
- Back pain
Pharmacology
- Half-life: 9-15h
- Metabolism: CYP3A4 and CYP2D6
- Excretion: Mostly renal
Mechanism of Action
- Alpha-1A antagonist→ smooth muscle relaxation in bladder neck, prostate, urethra→ increased urine flow rate